Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1H&P----1件: 226 💬
2H-116PI-DE.pdf----1件: 18 💬
3H-ATG (ATGAM )----1件: 60 💬
4H. pylori triple therapy----1件: 63 💬
5H.P. Acthar Gel----5件: 46, 49, 50, 84, 222 💬
6H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
7H.P. Acthar® Gel----1件: 14 💬
8H01BB02----1件: 193 💬
9H01C B03----1件: 77 💬
10H02 - Corticosteroidi Sistemici----1件: 299 💬
11H021----1件: 97 💬
12H02AB----1件: 97 💬
13H02AB02----1件: 28 💬
14H02AB02 Desametasone----1件: 28 💬
15H02AB04----1件: 46 💬
16H02AB07----1件: 46 💬
17H02AB09----1件: 41 💬
18H05AA02----1件: 274 💬
19H1 Blocker----1件: 257 💬
20H2 Blocker----1件: 257 💬
21H44AON188----1件: 113 💬
22H51AON23----1件: 113 💬
23H5G1.1-mAb----3件: 13, 50, 62 💬
24HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49 💬
25HA20 (IMMU-106)----1件: 46 💬
26Habitrol----1件: 84 💬
27Haemoblock----2件: 157, 280 💬
28Haemocomplettan P----1件: 65 💬
29Haemocomplettan(R) P----1件: 65 💬
30Haemocomplettan(R) P 1g/2g----1件: 65 💬
31HAEMOPHILUS INFLUENZAE----5件: 61, 62, 63, 66, 223 💬
32HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)----2件: 13, 14 💬
33Haemophilus type b vaccine (conjugated)----1件: 14 💬
34Haemostasis tests----1件: 113 💬
35HAESCs----1件: 6 💬
36HAESCs treatment----1件: 6 💬
37Halometasone1件: Halometasone1件: Halometasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 162 💬
38Haloperidol1件: Haloperidol3件: Haloperidol ,
Haloperidol decanoate ,
Haloperidol lactate 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
39Haloperidol 2Mg Tab1件: Haloperidol3件: Haloperidol ,
Haloperidol decanoate ,
Haloperidol lactate 💬 		1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8 💬
40Haplo HSCT----1件: 60 💬
41Haplo/cord transplant----1件: 60 💬
42Haploidentical donor bone marrow transplant----1件: 60 💬
43Haploidentical Hematopoietic Cell Transplantation----2件: 60, 65 💬
44Haploidentical hematopoietic cell transplantation combined with unrelated cord blood stem cells----1件: 60 💬
45Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
46Harmonized supportive care----2件: 38, 39 💬
47HATG----1件: 60 💬
48Havrix----1件: 46 💬
49HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)----1件: 6 💬
50HB-adMSCs----8件: 2, 4, 6, 13, 14, 46, 49, 113 💬
51HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells----2件: 17, 96 💬
52HB0034----1件: 37 💬
53HB2198----1件: 49 💬
54HBI-002----1件: 6 💬
55HBI0101 CART----5件: 11, 13, 46, 49, 51 💬
56HBM7020----3件: 46, 49, 51 💬
57HBM9161----1件: 14 💬
58HBM9161 Dose A----1件: 63 💬
59HBM9161 Dose B----1件: 63 💬
60HBM9161 Injection----1件: 13 💬
61HBM9161 Injection (340 mg)----1件: 11 💬
62HBM9161 Injection (680mg and 340 mg)----1件: 11 💬
63HBM9161 Injection (680mg)----1件: 11 💬
64HBVAXPRO----2件: 46, 50 💬
65HBVAXPRO 5 micrograms/0.5 ml----1件: 46 💬
66HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA)----1件: 46 💬
67HBVAXPRO® 40 micrograms----1件: 46 💬
68HC-58----1件: 149 💬
69HC022----1件: 49 💬
70HCQ----2件: 46, 49 💬
71HCQ/CQ and CAB combined treatment----1件: 74 💬
72HCT----1件: 67 💬
73HD-DXM----1件: 63 💬
74HD-TIV----1件: 46 💬
75HE3286----2件: 46, 97 💬
76Healthy donor-derived FMT capsule----1件: 6 💬
77HEC 68498----1件: 85 💬
78HEC122505MsOH----1件: 6 💬
79HEC585----1件: 85 💬
80Helicobacter pylori eradication therapy----1件: 6 💬
81Helium1件: Helium1件: Helium 💬 --3件: 228, 299, 330 💬
82Helminth ova----1件: 13 💬
83Helopanflat Mono®----1件: 298 💬
84Hematide, peginesatide1件: Peginesatide2件: Peginesatide ,
Peginesatide acetate 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
85Hematopoetic stem cell infusion----1件: 13 💬
86Hematopoetic Stem Cell Transplantation----6件: 19, 65, 121, 160, 308, 326 💬
87Hematopoietic bone marrow transplantation----1件: 36 💬
88Hematopoietic Cell Transplantation----2件: 49, 60 💬
89Hematopoietic stem cell infusion----2件: 19, 20 💬
90Hematopoietic Stem Cell Therapy----1件: 13 💬
91Hematopoietic Stem Cell Transplant----2件: 65, 285 💬
92Hematopoietic stem cell transplant (HSCT)----1件: 65 💬
93Hematopoietic Stem Cell Transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
94Hematopoietic stem cell transplantation (HSCT)----2件: 13, 60 💬
95Hemay005----2件: 56, 271 💬
96Hemay005 tablet----1件: 97 💬
97Hemay005 tablets----1件: 97 💬
98Hemay007----1件: 97 💬
99Hemay007 1200 mg QD group----1件: 46 💬
100Hemay007 600 mg QD group----1件: 46 💬
101Hemay007 800 mg QD group----1件: 46 💬
102Heme arginate1件: Heme arginate---1件: 254 💬
103Hemin1件: Hemin1件: Hemin 💬 2件: ALAS1,
ALAS2 💬 		2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
104Hemin for injection1件: Hemin1件: Hemin 💬 2件: ALAS1,
ALAS2 💬 		2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
105Hemlibra®----1件: 288 💬
106Hemoglobin1件: Hemoglobin---3件: 6, 60, 283 💬
107Henagliflozin1件: Henagliflozin---3件: 58, 66, 218 💬
108Henagliflozin (SGLT2 Inhibitor)1件: Henagliflozin---1件: 58 💬
109Heparesc----1件: 251 💬
110Heparin1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬15件: 47, 48, 60, 65, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317, 344 💬
111Heparin & Alkalinized Lidocaine Bladder Instillation2件: Heparin,
Lidocaine		5件: Lidocaine ,
Lidocaine hydrochloride ,
Heparin sodium ,
Heparin calcium ,
Lidocaine hydrochloride monohydrate 💬 		7件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A,
SERPINC1 💬 		6件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Complement and coagulation cascades, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬1件: 226 💬
112Heparin 25mg inhalation powder, hard capsule1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 299 💬
113Heparin calcium5,000 U twice daily plus low dose aspirin1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 48 💬
114Heparin Sodium1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬2件: 280, 299 💬
115Heparin-induced extracorporeal LDL precipitation1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 79 💬
116Heparán N sulfatasa humana recombinante----1件: 19 💬
117Heparán N sulfatasa humana recombinante (rhHNS)----1件: 19 💬
118HepaStem----1件: 251 💬
119HepaStem Infusion----1件: 251 💬
120Hepatitis A Vaccine1件: Hepatitis A Vaccine---3件: 46, 96, 97 💬
121Hepatitis A vaccine ( HAVRIX or EPAXAL)1件: Hepatitis A Vaccine---1件: 46 💬
122Hepatitis A vaccine and tetanus vaccine1件: Hepatitis A Vaccine---1件: 46 💬
123Hepatitis B vaccine----1件: 97 💬
124HEPATITIS B VACCINE (RDNA)----1件: 46 💬
125HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN)----1件: 46 💬
126Hepatocyte Transplant----1件: 240 💬
127Heptaminol1件: Heptaminol2件: Heptaminol ,
Heptaminol hydrochloride 💬 		--1件: 6 💬
128Heptaminol hydrochloride1件: Heptaminol2件: Heptaminol ,
Heptaminol hydrochloride 💬 		--1件: 6 💬
129HER-096----1件: 6 💬
130Heracillin----1件: 299 💬
131Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)----1件: 6 💬
132Herbal medicine----1件: 70 💬
133Herbal treatment (SA100)----1件: 97 💬
134Hericium erinaceus mycelium----1件: 6 💬
135Herombopag----2件: 60, 63 💬
136Herombopag + CsA----1件: 60 💬
137Herombopag olamine tablets----1件: 63 💬
138Herpes Zoster Subunit (HZ/su) Vaccine----1件: 49 💬
139Herpes Zoster Vaccine----3件: 46, 96, 271 💬
140HESC-RPE----1件: 301 💬
141Hesperidin1件: Hesperidin1件: Hesperidin 💬 --3件: 13, 46, 93 💬
142Heterologous booster----1件: 13 💬
143Heterologous Human Adult Liver-derived Progenitor Cells----1件: 251 💬
144Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC)----1件: 251 💬
145Hetrombopag1件: Hetrombopag---2件: 60, 63 💬
146Hetrombopag 5mg po qd1件: Hetrombopag---1件: 63 💬
147Hetrombopag Olamine1件: Hetrombopag---2件: 60, 63 💬
148Hetrombopag Olamine Tablet1件: Hetrombopag---1件: 60 💬
149Hetrombopag Olamine+Standard Therapy1件: Hetrombopag---1件: 60 💬
150Hextend----2件: 96, 97 💬
151HF0220----1件: 6 💬
152HF2----1件: 97 💬
153HFNT during exercise----1件: 299 💬
154Hgd40----1件: 97 💬
155HGP1206----1件: 86 💬
156HGPIV diagnosis test----1件: 299 💬
157HGS1006----1件: 49 💬
158HGS1006, LymphoStat-B----1件: 53 💬
159HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA----2件: 49, 53 💬
160HGS1025----1件: 97 💬
161HGT-1110----1件: 19 💬
162HGT-1111----1件: 19 💬
163HGT-1410----1件: 19 💬
164HGT-2310----1件: 19 💬
165HHALPC----1件: 251 💬
166HHLivC----1件: 251 💬
167Hiberix----1件: 13 💬
168HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML----5件: 61, 62, 63, 66, 223 💬
169HIDONAC*EV 1FL 5G 25ML----1件: 51 💬
170Hidrocloruro de efedrina1件: Ephedrine3件: Ephedrine ,
Ephedrine hydrochloride ,
Ephedrine sulfate 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11 💬
171Hidrocloruro de fingolimod1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
172HIDROFEROL----1件: 113 💬
173Hidroferol®----1件: 113 💬
174HIDS DONOR----1件: 19 💬
175High cheese intake.----1件: 238 💬
176High Cut-off Hemodialysis----1件: 28 💬
177High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device----1件: 226 💬
178High Dietary Sodium----1件: 49 💬
179High dose----1件: 97 💬
180High dose AFFITOPE® PD03A + Adjuvant----1件: 6 💬
181High dose ANAVEX2-73----1件: 6 💬
182High Dose Aspirin (1300 mg/day)----1件: 13 💬
183High dose BIBF 1120 twice daily----1件: 85 💬
184High Dose Budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
185High dose budesonide rectal foam1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
186High dose budesonide suspension1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
187High dose budesonide tablet1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
188High dose dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
189High dose Dexamethasone pulses1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
190High dose GR1603 in phase ?----1件: 49 💬
191High dose GR1603 in phase?b----1件: 49 💬
192High Dose GT-02287----1件: 6 💬
193High dose influenza vaccine (HDIV)----1件: 97 💬
194High dose lactulose1件: Lactulose1件: Lactulose 💬 --1件: 291 💬
195High dose levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
196High Dose Mesenchymal Stem Cells (MSCs)----1件: 49 💬
197High Dose MT-1303----1件: 97 💬
198High Dose MYOBLOC (20,000 Units)----1件: 13 💬
199High dose of BIIL 284 BS tablets----1件: 46 💬
200High dose of budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 299 💬
201High dose of MRM-3379----1件: 206 💬
202High dose ORTD-1----1件: 46 💬
203High dose TSO----1件: 96 💬
204High dose vehicle control----1件: 46 💬
205High Dose-VIS649----1件: 66 💬
206High doses of Thiamine y Biotin2件: Biotin,
Thiamine		4件: Biotin ,
Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--1件: 8 💬
207High Fiber supplement----1件: 6 💬
208High frequency ultrasonography----1件: 46 💬
209High gluten diet----1件: 97 💬
210High MCT formula----1件: 296 💬
211High milk intake.----1件: 238 💬
212High Oligosaccharide Group----1件: 96 💬
213High Phenolic Extra Virgin Olive Oil1件: Olive oil1件: Olive oil 💬 --1件: 13 💬
214High Protein and Low Fiber Diet----1件: 97 💬
215High protein high fiber diet----2件: 93, 95 💬
216High Protein. T-Diet plus Range----1件: 6 💬
217High serine diet1件: Serine1件: Serine 💬 --1件: 96 💬
218High water intake1件: Water1件: Water 💬 --1件: 67 💬
219High-caloric fatty diet----1件: 2 💬
220High-carbohdyrate breakfast----1件: 265 💬
221High-Ceiling Diuretics----1件: 57 💬
222High-dose calcium (400 mg x 4), vitamin D (19 mikg x 4), and active vitamin D supplementation (2 mikg x 2)2件: Calcium,
Vitamin D		---1件: 235 💬
223High-Dose CICR-NAM----1件: 97 💬
224High-dose corticosteroid pulse therapy----1件: 13 💬
225High-dose Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 96 💬
226High-dose Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
227High-Dose Dexamethasone Combined1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
228High-Dose Dexamethasone Combined with Orelabrutinib2件: Dexamethasone,
Orelabrutinib		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib 💬 		2件: BTK,
NR3C1 💬 		8件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
229High-dose intravenous immunoglobulin (IVIG)----1件: 18 💬
230High-dose intravenous immunoglobulin (Venoglobulin-IH)----1件: 51 💬
231High-dose intravenous methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
232High-dose MH002----1件: 97 💬
233High-dose REGN4461----1件: 265 💬
234High-dose vitamin D (2000 IU per day)1件: Vitamin D---1件: 274 💬
235High-Dose Vitamin D3----1件: 299 💬
236High-Frequency-Only Stimulation----1件: 6 💬
237High-Intensity Focused Electromagnetic Therapy----1件: 13 💬
238High-intensity lipid-lowering therapy----2件: 46, 49 💬
239High-resolution peripheral quantitative computed tomography (HR-pQCT)----1件: 46 💬
240High/Low Sodium Diet----1件: 13 💬
241Higher Dose of Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
242Higher-volume C1-esterase inhibitor----1件: 65 💬
243Himan Normal Immunoglobulin----1件: 14 💬
244Hiomega-3 supplement of Naturalis® company -----1件: 49 💬
245HiPSC-CM therapy----1件: 57 💬
246HiSCs----1件: 46 💬
247Histamine1件: Histamine3件: Histamine dihydrochloride ,
Histamine phosphate ,
Histamine 💬 		4件: HRH1,
HRH2,
HRH3,
HRH4 💬 		5件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 13 💬
248Histidine1件: Histidine1件: Histidine 💬 --3件: 13, 169, 170 💬
249Histone Deacetylase Inhibitor----1件: 127 💬
250History and physical----1件: 231 💬
251History and physical exam.----2件: 231, 299 💬
252Histrelin1件: Histrelin2件: Histrelin acetate ,
Histrelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
253Histrelin Subcutaneous Implant1件: Histrelin2件: Histrelin acetate ,
Histrelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
254HIV Anti-retroviral Background Therapy----1件: 265 💬
255Hizentra----4件: 14, 50, 51, 65 💬
256HIZENTRA ®----1件: 11 💬
257Hizentra®----2件: 14, 65 💬
258HK-001----1件: 2 💬
259HK-660S----1件: 94 💬
260HK-660S 100mg----1件: 94 💬
261HK-660S 200mg----1件: 94 💬
262HL-085----1件: 34 💬
263HL-400----1件: 6 💬
264HL161BKN----1件: 14 💬
265HL237----1件: 46 💬
266HL237 tablet----1件: 46 💬
267HLA-identical allogeneic mesoangioblasts----1件: 113 💬
268HLB-001----1件: 246 💬
269HLL2----1件: 49 💬
270HLL2 (Epratuzumab)1件: Epratuzumab1件: Epratuzumab 💬 1件: CD22 💬 3件: B cell receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Hematopoietic cell lineage 💬1件: 49 💬
271HLL2 (trivial name or chemical description)----1件: 49 💬
272HLL2,IMMU-103----1件: 49 💬
273HLX-1502----1件: 34 💬
274HLX01----1件: 46 💬
275HM15421/GC1134A----1件: 19 💬
276HM201----2件: 96, 97 💬
277HM71224 food effect----1件: 46 💬
278HM71224 Multiple ascending dose----1件: 46 💬
279HM71224 single ascending dose----1件: 46 💬
280HMABs----1件: 113 💬
281HMB----1件: 96 💬
282HMED-IdeS----2件: 64, 221 💬
283HMG Coenzyme reductase----1件: 79 💬
284HMG-Coenzyme inhibitor (statin)----1件: 218 💬
285HMI-1031件: HMI-103---1件: 240 💬
286HMI-2031件: HMI-203---1件: 19 💬
287HMPL-004----2件: 96, 97 💬
288HMPL-004 1800 mg/day----1件: 97 💬
289HMPL-004 2400 mg/day----1件: 97 💬
290HMPL-004 high dose----1件: 97 💬
291HMPL-004 low dose----1件: 97 💬
292HMPL-523----2件: 46, 63 💬
293HMPL-523(300mg PO QD)----1件: 61 💬
294HMPL004-6599----2件: 96, 97 💬
295HMR 1726D----1件: 13 💬
296HMR1726----1件: 13 💬
297HMR1726D----1件: 13 💬
298HMSCs----1件: 299 💬
299HN2301 injection----4件: 11, 46, 49, 51 💬
300HN2302 Injection----3件: 11, 49, 51 💬
301HNC364----1件: 6 💬
302HNC364 Injectable Suspension----1件: 6 💬
303HNSC----1件: 2 💬
304HNSC-01----1件: 8 💬
305Hologene 5----1件: 36 💬
306Hologene 5Pharmaceutical Form: Living tissue equivalentINN or Proposed INN: Not Yet AssignedCAS Number: Not AppCurrent Sponsor code: Hologene 5 DSOther descriptive name: Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vectorConcentration unit: U unit(s)Concentration type: rangeConcentration number: 20000000-30000000----1件: 36 💬
307HOLOGENE17----1件: 36 💬
308HOLOGENE7----1件: 36 💬
309HOMAR-IR diagnosis test----1件: 299 💬
310Home based balance training----2件: 6, 13 💬
311Home Oral Glucose Tolerance Test kit----1件: 299 💬
312Homeostasis Model Assessment of insulin resistance (HOMA)----1件: 17 💬
313Homocysteine1件: Homocysteine---1件: 229 💬
314Homologous booster----1件: 13 💬
315HOMSC300----1件: 17 💬
316Honey1件: Honey1件: Honey 💬 --4件: 57, 63, 98, 230 💬
317Hookworm larvae----1件: 13 💬
318HORA-PDE6B (AAV2/5.hPDE6B)----1件: 90 💬
319Hormonal balance measurements----1件: 81 💬
320Hormonal profile----1件: 113 💬
321Hormone (prednisone)1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
322Horse Anti-thymocyte Globulin----2件: 285, 326 💬
323Horse anti-thymocyte globulin (ATG)----1件: 60 💬
324Horse anti-thymocyte globulin (hATG)----1件: 60 💬
325Horse chestnut1件: Horse chestnut1件: Horse chestnut 💬 --1件: 210 💬
326Horse-Anti-thymocyte-Globulin----1件: 60 💬
327Hospital-Based Vaccination Pathway----1件: 97 💬
328Hourly dosing of the nychtemeral secretion of melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
329HOV-120201件: HOV-12020---2件: 6, 124 💬
330HOV-12020 (Palm tocotrienols complex)1件: HOV-12020---1件: 124 💬
331HP 129Xe----1件: 299 💬
332Hp 129Xenon----1件: 228 💬
333HP 13C pyruvate injection----1件: 13 💬
334HP 3He----1件: 299 💬
335HP184----1件: 13 💬
336HP802-247----1件: 36 💬
337HPC cell infusion----1件: 45 💬
338HPC, A Infusion----1件: 60 💬
339HPN-100----1件: 251 💬
340HPV prophylactic vaccine Gardasil----1件: 49 💬
341HR19042 capsule----1件: 66 💬
342HR19042 Capsule, Tarpeyo®, Budenofalk®----2件: 66, 95 💬
343HR19042 Capsules----2件: 66, 95 💬
344HRA052015----1件: 75 💬
345HRA052015 (mifepristone)1件: Mifepristone1件: Mifepristone 💬 2件: NR3C1,
PGR 💬 		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75 💬
346HRG2010----1件: 6 💬
347HRG2010 Capsule, Sinemet®, Madopar®----1件: 6 💬
348HRG2010(I)----1件: 6 💬
349HRG2010(II)----1件: 6 💬
350HrIL-2 active----3件: 46, 49, 53 💬
351HRPC----1件: 90 💬
352HRPC DP----1件: 90 💬
353HRS-1893----1件: 58 💬
354HRS-1893 Tablet----1件: 58 💬
355HRS-1893 Tablets----1件: 58 💬
356HRS-5965----2件: 66, 223 💬
357HRS-5965 capsule----1件: 62 💬
358HRS-5965 Capsules----2件: 62, 66 💬
359HRS-5965 tablets----2件: 62, 66 💬
360HRS-7085----1件: 97 💬
361HRS-7085 tablets----1件: 97 💬
362HRS-9813----1件: 85 💬
363HS-10390----1件: 66 💬
364HS-10390 tablet----2件: 66, 222 💬
365HS-10511 Tablets----1件: 58 💬
366HS-10542----1件: 62 💬
367HS-10542 High Dose----1件: 66 💬
368HS-10542 Low Dose----1件: 66 💬
369HS135----1件: 86 💬
370HS235----1件: 86 💬
371HS628+MTX----1件: 46 💬
372HS_SW01 cells injection----2件: 51, 271 💬
373HSK31858----1件: 299 💬
374HSK31858, tablet----1件: 299 💬
375HSK39297----2件: 62, 66 💬
376HSK39297 100mgBID----1件: 66 💬
377HSK39297 200mgQD----1件: 66 💬
378HSK39297 300mgQD----1件: 66 💬
379HSK39297 50mgBID----1件: 66 💬
380HSK39297 tablets----1件: 62 💬
381HSK44459----1件: 85 💬
382HSK44459 dose 1----1件: 85 💬
383HSK44459 dose 2----1件: 85 💬
384HSK44459 dose 3----1件: 85 💬
385HSK47388----1件: 97 💬
386HST5040----2件: 245, 246 💬
387HT-100----1件: 113 💬
388HTD1801----1件: 94 💬
389HTEA----1件: 57 💬
390HTK cardioplegia----1件: 215 💬
391Hu Leptin (A-100)1件: Leptin---1件: 265 💬
392Hu MiK-Beta-1----1件: 26 💬
393Hu-G012267----1件: 65 💬
394Huaier granule----1件: 222 💬
395Huaiqihuang Granule----2件: 63, 222 💬
396Huaiqihuang granules----1件: 223 💬
397Huaiqinhuang----1件: 224 💬
398Huang qi gui zhi wu wu granule----1件: 46 💬
399HUC-MSC----1件: 218 💬
400HUC-MSC + DMARDs----1件: 46 💬
401HUC-MSC infusion (BC-U001)----1件: 46 💬
402HUC-MSC suspension----1件: 46 💬
403HUC-MSC-sEV-001 nasal drops----3件: 2, 6, 17 💬
404HUC-MSCs treatment (Double dose)----1件: 49 💬
405HUC-MSCs treatment (high dose)----1件: 49 💬
406HUC-MSCs treatment (low dose)----1件: 49 💬
407HUC-MSCs treatment (medium dose)----1件: 49 💬
408HuCNS-SC----1件: 19 💬
409HuCNS-SC cells----1件: 139 💬
410HuCNS-SC transplant in the lead-in phase----1件: 139 💬
411HuL001----1件: 85 💬
412Hulio----2件: 96, 97 💬
413HuM291----2件: 96, 97 💬
414HuM291)----1件: 97 💬
415Human acylated ghrelin----1件: 78 💬
416HUMAN ALBUMIN AS MACROAGGREGATES----1件: 96 💬
417HUMAN ALBUMIN SOLUTION----1件: 2 💬
418Human allogeneic adipose tissue-derived mesenchymal stem cells expanded----1件: 36 💬
419Human allogeneic induced pluripotent stem cell (iPSC)-derived dopaminergic neural progenitor cell injection----1件: 6 💬
420Human Allogeneic Induced Pluripotent Stem Cells (iPSCs) -Derived Motor Neuron Progenitor Cells (XS228CN)----1件: 2 💬
421Human Allogeneic WJ-MSCs----1件: 36 💬
422Human Amniotic Epithelial Stem Cells----1件: 6 💬
423Human anti TNF-alpha monoclonal----1件: 46 💬
424Human anti TNF-alpha monoclonal antibody----2件: 46, 84 💬
425Human anti-IL 12/23 monoclonal antibody----1件: 84 💬
426Human Anti-IL-12 Antibody----1件: 96 💬
427Human anti-IL-12 IgG1 Mab----1件: 13 💬
428Human anti-IL-12 Mab----1件: 13 💬
429Human anti-IL6 monoclonal antibody----1件: 46 💬
430Human anti-IP10 monoclonal antibody----2件: 96, 97 💬
431Human anti-LINGO-1 monoclonal antibody----1件: 13 💬
432HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----1件: 3 💬
433Human Anti-TNF IgG1 Monoclonal Antibody----3件: 46, 97, 271 💬
434Human anti-TNF-alpha monoclonal antibody----3件: 46, 97, 107 💬
435Human anti-TNFa monoclonal antibody----1件: 271 💬
436Human Anti-TNFalfa----3件: 46, 97, 271 💬
437Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody----1件: 51 💬
438Human autologous mesenchymal stem cells----2件: 2, 13 💬
439Human Bone Marrow Mesenchymal Stem Cell (hBMMSC)----1件: 229 💬
440Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh----1件: 36 💬
441Human Dopaminergic Progenitor Cells----2件: 6, 17 💬
442Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)----1件: 90 💬
443Human fetal-derived Neural Stem Cells (hNSCs)----1件: 13 💬
444HUMAN FIBRINOGEN----1件: 65 💬
445Human Fibrinogen Concentrate----1件: 65 💬
446Human fibroblast-derived dermal substitute, Dermagraft----1件: 36 💬
447Human Glucocerebrosidase (prGCD)----1件: 19 💬
448Human Growth Hormone (1-134)----1件: 78 💬
449Human Heterologous Liver Cells----1件: 251 💬
450Human heterologous liver cells (for infusion)----1件: 251 💬
451Human IgG1 monoclonal antibody against alpha-synuclein----1件: 17 💬
452HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY----1件: 60 💬
453Human IgG4 monoclonal antibody against CD40----1件: 46 💬
454Human Immunglobulin G (IgG)----1件: 65 💬
455Human Immunoglobulin----2件: 63, 65 💬
456Human immunoglobulin (pH4) for intravenous injection----1件: 63 💬
457HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G1件: Globulin, immune 💬 --4件: 14, 50, 63, 65 💬
458Human immunoglobulin intravenous----1件: 63 💬
459Human insulin----1件: 35 💬
460Human interferon beta1件: Human interferon beta1件: Interferon beta 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 26 💬
461Human interferon beta 1a (Rebif)1件: Human interferon beta1件: Interferon beta 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
462Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		3件: Interferon beta ,
Glatiramer acetate ,
Interferon beta-1a 💬 		22件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬 		44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Coronavirus disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
463Human interleukin-21件: Human interleukin-21件: Celmoleukin 💬 3件: IL2RA,
IL2RB,
IL2RG 💬 		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 35 💬
464Human interleukin-61件: Human interleukin-6---1件: 46 💬
465HUMAN LEUCOCYTE INTERFERON-ALPHA----1件: 13 💬
466HUMAN MESENCHYMAL STEM CELLS----1件: 71 💬
467Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----1件: 96 💬
468Human monoclonal antibody (CNTO 1275) to interleukin-12p40----1件: 13 💬
469Human monoclonal antibody directed against CD20 on B-cells----1件: 46 💬
470Human monoclonal antibody directed against complement 5 protein----1件: 62 💬
471Human N-sulfoglucosamine sulfohydrolase fused to a humanised monoclonal antibody targeting human transferrin receptor----1件: 19 💬
472Human neural stem cell----1件: 6 💬
473Human Neural Stem Cells----2件: 2, 13 💬
474Human normal 10% immunoglobulin for intravenous administration----1件: 14 💬
475Human normal 10% immunoglobulin for intravenous administrationn----1件: 14 💬
476Human normal immunoglobulin----6件: 13, 14, 50, 51, 63, 65 💬
477HUMAN NORMAL IMMUNOGLOBULIN (IV)----4件: 11, 14, 63, 65 💬
478Human normal immunoglobulin (IVIg)----3件: 14, 50, 65 💬
479Human normal immunoglobulin (SCIg)----1件: 14 💬
480Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)----1件: 65 💬
481Human normal immunoglobulin (subcutaneous)----1件: 65 💬
482HUMAN NORMAL IMMUNOGLOBULIN FOR----1件: 65 💬
483Human normal immunoglobulin for intravenous (IV) administration----1件: 51 💬
484Human normal immunoglobulin for intravenous administration----3件: 14, 51, 65 💬
485HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE----2件: 63, 65 💬
486Human normal immunoglobulin for intravenous use (IVIG)----1件: 65 💬
487HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE----1件: 63 💬
488Human normal immunoglobulin for subcutaneous administration----2件: 51, 65 💬
489Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)----1件: 65 💬
490Human normal immunoglobulin G (IgG > 98% purity)----3件: 14, 63, 65 💬
491Human normal immunoglobulin G (IgG)----1件: 11 💬
492Human normal immunoglogulin (IVIg)----1件: 50 💬
493Human papillomavirus vaccination (Gardasil)----1件: 49 💬
494Human Papillomavirus Vaccine----1件: 97 💬
495Human Placenta-Derived Cells PDA001 Intravenous Infusion----1件: 96 💬
496Human Placental Derived Stem Cell----4件: 19, 20, 60, 284 💬
497HUMAN PLASMA FOR FRACTIONATION----1件: 96 💬
498Human primary Retinal Pigment Epithelial (HuRPE) cells----1件: 90 💬
499Human recombinant growth hormone----2件: 13, 299 💬
500Human Recombinant IgG1, lambda----1件: 46 💬
501Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: Metreleptin 💬 1件: LEPR 💬 7件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
502Human recombinant parathyroid Hormone1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬 		4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
503Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein1件: Alkaline Phosphatase---1件: 172 💬
504Human retinal progenitor cells----1件: 90 💬
505Human Retinal Progenitor Cells Drug Product----1件: 90 💬
506Human Secretin----1件: 298 💬
507Human soluble recombinant Fc-gamma receptor IIB----1件: 66 💬
508Human Stem Cells----1件: 6 💬
509Human TH-SC01 cell injection----1件: 96 💬
510Human Transthyretin Antisense Oligonucleotide----1件: 28 💬
511Human Umbilical Cord Blood-derived Mesenchymal Stem Cells----1件: 36 💬
512Human umbilical cord derived MSC transplantation for SLE----1件: 49 💬
513Human umbilical cord mesenchymal stem cell injection----1件: 85 💬
514Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---5件: 13, 96, 97, 113, 271 💬
515Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 113 💬
516Human umbilical cord-derived MSCs----1件: 271 💬
517Human Wharton's jelly-derived mesenchymal stem cells----1件: 10 💬
518Human-derived stromal cells----1件: 6 💬
519Humanised anti-CD 20 antibody----1件: 46 💬
520Humanised anti-CD4 IgG1 monoclonal----1件: 46 💬
521Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2----1件: 49 💬
522Humanised IgG1 monoclonal antibody against human eotaxin-2----1件: 94 💬
523Humanised IgG1 monoclonal antibody against misfolded transthyretin----1件: 28 💬
524Humanised IgG1K monoclonal antibody against interferon beta----1件: 50 💬
525Humanised IgG1k monoclonal antibody against KIT----1件: 98 💬
526Humanised VHH-type bispecific antibody against Complement component 5 and serum albumin----1件: 11 💬
527Humanised VHH-type bispecific antibody that binds to Complement component 5 and serum albumin----1件: 11 💬
528Humanized anti-alpha v beta 6 mAb----1件: 85 💬
529Humanized anti-Factor Bb monoclonal antibody----1件: 62 💬
530Humanized IgG1 kappa antiamyloid----1件: 28 💬
531Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody----1件: 28 💬
532Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----1件: 46 💬
533Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97 💬
534Humanized TNFa monoclonal antibody----1件: 46 💬
535Humatrope----1件: 274 💬
536Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten----1件: 193 💬
537HuMax-CD201件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 13, 46 💬
538HUMAX-CD38----2件: 28, 63 💬
539HuMax-CD38, 3003-005----1件: 28 💬
540HuMax-CD4----1件: 46 💬
541HUMIRA----9件: 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
542Humira (adalimumab original)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97 💬
543HUMIRA (ADALIMUMAB)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
544Humira (adalimumab) 40 mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
545Humira (adalimumab) 40 mg s.c. injection1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
546Humira (adalimumab) 40mg in 0.4 ml s.c. injection1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
547Humira (adalimumab) 40mg in 0.4ml s.c.injection1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
548HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER----2件: 56, 97 💬
549HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER----1件: 46 💬
550HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL----2件: 46, 96 💬
551Humira 20 mg solution for injection in pre-filled syringe----1件: 96 💬
552Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)----1件: 97 💬
553Humira 40 mg injekcní roztok v predplnené injekcní stríkacce----1件: 96 💬
554Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte----1件: 46 💬
555HUMIRA 40 mg solución inyectable en jeringa precargada----2件: 46, 96 💬
556Humira 40 mg solution for injection in pre-filled pen----1件: 96 💬
557Humira 40 mg solution for injection in pre-filled syringe----3件: 46, 96, 97 💬
558Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)----1件: 97 💬
559Humira 40 mg solution for injection in pre-filled syringes----1件: 97 💬
560Humira 40 mg/0.8 ml solution for injection----4件: 46, 96, 97, 271 💬
561Humira 40 mg/0.8 ml solution for injection for paediatric use----1件: 97 💬
562Humira 40mg Injektionslösung----1件: 46 💬
563HUMIRA 40Mg Solution for Injection----2件: 96, 97 💬
564Humira 40mg solution for injection in pre-filled syringe----1件: 46 💬
565Humira 40mg solution for injection in pre-filled syringe (adalimumab)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
566Humira 40mg, solution injectable en stylo prérempli----1件: 56 💬
567Humira 40mg/0.4ml pre-filled syringe----2件: 96, 97 💬
568Humira 40mg/0.8 ml solution for injection for paediatric use----1件: 46 💬
569Humira 40mg/0.8ml solution for injection for paediatric use----1件: 96 💬
570Humira 40mg/0.8ml solution for injection in pre-filled syringe----1件: 46 💬
571Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)----1件: 97 💬
572Humira pre-filled PEN----1件: 96 💬
573Humira SC----1件: 46 💬
574HUMIRA ®----2件: 96, 97 💬
575Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
576HUMIRA*SC 2SIR+F 40MG 0,8ML+2T----2件: 46, 96 💬
577Humira, 40 mg solution for injection in pre-filled syringe----1件: 46 💬
578Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi----1件: 46 💬
579Humira®----5件: 46, 96, 97, 107, 271 💬
580Humira® (adalimumab)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
581Humira® 40 mg Injektionslösung in Fertigspritze----1件: 46 💬
582Humira® 40 mg solution for injection in pre-filled syringe----1件: 46 💬
583Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe----1件: 46 💬
584Hunterase----1件: 19 💬
585Huolingshengji Granules----1件: 2 💬
586Huoluo Pills----1件: 46 💬
587HW201877 capsules----1件: 97 💬
588HW241045 Formulation A----1件: 85 💬
589HW241045 Formulation B----1件: 85 💬
590Hyaluronic acid1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--5件: 46, 53, 70, 226, 231 💬
591Hyaluronic Acid (HA)1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 226 💬
592Hyaluronic Acid and Chondroitin Sulfate2件: Chondroitin sulfate,
Hyaluronic acid		3件: Chondroitin sulfate A ,
Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 226 💬
593Hyaluronic Acid Inhalation Solution1件: Hyaluronic acid2件: Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 231 💬
594Hyaluronic acid/chondroitin sulfate2件: Chondroitin sulfate,
Hyaluronic acid		3件: Chondroitin sulfate A ,
Hyaluronate sodium ,
Hyaluronic acid 💬 		--1件: 226 💬
595Hyaluronidase1件: Hyaluronidase3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--7件: 13, 14, 28, 51, 60, 65, 331 💬
596Hyaluronidase injected intradermally1件: Hyaluronidase3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--1件: 51 💬
597Hydralazine1件: Hydralazine3件: Hydralazine hydrochloride ,
Hydralazine polistirex ,
Hydralazine 💬 		1件: AOC3 💬 4件: Glycine, serine and threonine metabolism, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism 💬1件: 67 💬
598Hydrochloorthiazide----1件: 225 💬
599HYDROCHLOROTHIAZIDE1件: Hydrochlorothiazide1件: Hydrochlorothiazide 💬 1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬5件: 13, 67, 222, 225, 235 💬
600Hydrochlorothiazide 25 mg1件: Hydrochlorothiazide1件: Hydrochlorothiazide 💬 1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬1件: 67 💬
601Hydrochlorothiazide/amiloride2件: Amiloride,
Hydrochlorothiazide		3件: Hydrochlorothiazide ,
Amiloride hydrochloride ,
Amiloride 💬 		4件: SCNN1A,
SCNN1B,
SCNN1G,
SLC12A3 💬 		3件: Aldosterone-regulated sodium reabsorption, Parathyroid hormone synthesis, secretion and action, Taste transduction 💬1件: 225 💬
602Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----1件: 83 💬
603Hydrocortisone1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
604Hydrocortisone (Solucortef)1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
605HYDROCORTISONE - hydrocortisone tablet1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
606Hydrocortisone 100mg/ml1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
607Hydrocortisone 10mg1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
608Hydrocortisone 10mg Tablet1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
609Hydrocortisone 10mg Tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
610Hydrocortisone 20mg Tablets1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
611HYDROCORTISONE ACETATE3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
612Hydrocortisone cream1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
613Hydrocortisone cream 1%1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
614Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 6 💬
615HYDROCORTISONE HYDROGEN SUCCINATE2件: Hydrocortisone,
Hydrogen		1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
616HYDROCORTISONE MICRONIZED1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
617Hydrocortisone Modified Release Capsules1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
618HYDROCORTISONE ROUSSEL1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
619Hydrocortisone sodium acetate3件: Acetate,
Hydrocortisone,
Sodium acetate		2件: Hydrocortisone ,
Sodium acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
620HYDROCORTISONE SODIUM PHOSPHATE2件: Hydrocortisone,
Hydrocortisone phosphate		2件: Hydrocortisone ,
Hydrocortisone sodium phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 53, 81, 83 💬
621HYDROCORTISONE SODIUM SUCCINATE3件: Hydrocortisone,
Hydrocortisone succinate,
Succinic acid		3件: Hydrocortisone ,
Hydrocortisone sodium succinate ,
Hydrocortisone succinate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 81, 83, 97 💬
622Hydrocortisone tablet 2.5 mg1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
623Hydrocortisone TAKEDA, tabletter1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 78 💬
624Hydrocortisone withdrawal1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
625HYDROCORTISONE- hydrocortisone tablet1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 81 💬
626Hydrocortisonum1件: Hydrocortisone1件: Hydrocortisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 83 💬
627Hydrocortone----1件: 78 💬
628Hydrogen1件: Hydrogen---8件: 5, 6, 13, 17, 83, 97, 226, 238 💬
629Hydrogen peroxide2件: Hydrogen,
Hydrogen peroxide		1件: Hydrogen peroxide 💬 --1件: 13 💬
630Hydrokortison----1件: 41 💬
631Hydrokortison APL kapsel 2,5 mg----1件: 83 💬
632Hydrokortison Glostrup 5 mg----1件: 78 💬
633Hydrokortison orion----1件: 41 💬
634Hydrolyzed guar gum1件: Guar gum1件: Guar gum 💬 --1件: 6 💬
635Hydromorphone1件: Hydromorphone2件: Hydromorphone hydrochloride ,
Hydromorphone 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 70 💬
636Hydroxocobalamin1件: Hydroxocobalamin2件: Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--3件: 97, 246, 337 💬
637Hydroxocobalamin Chloride Injection1件: Hydroxocobalamin2件: Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--2件: 246, 337 💬
638Hydroxocobalamin with Butyrate1件: Hydroxocobalamin2件: Hydroxocobalamin ,
Hydroxocobalamin acetate 💬 		--1件: 97 💬
639Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
640Hydroxychloroquine (HCQ)1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--2件: 6, 53 💬
641Hydroxychloroquine (Z0188)1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 49 💬
642Hydroxychloroquine + low-dose prednisone2件: Hydroxychloroquine,
Prednisone		3件: Prednisone ,
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
643Hydroxychloroquine + Prednisone2件: Hydroxychloroquine,
Prednisone		3件: Prednisone ,
Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 84 💬
644Hydroxychloroquine 400mg/d1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 53 💬
645Hydroxychloroquine and SoC1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--2件: 66, 223 💬
646Hydroxychloroquine higher dose1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 90 💬
647Hydroxychloroquine lower dose1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 90 💬
648Hydroxychloroquine or Chloroquine2件: Chloroquine,
Hydroxychloroquine		6件: Hydroxychloroquine sulfate ,
Chloroquine phosphate ,
Chloroquine ,
Chloroquine hydrochloride ,
Chloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 49 💬
649Hydroxychloroquine Oral Tablet1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--2件: 63, 66 💬
650Hydroxychloroquine Pill1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 13 💬
651Hydroxychloroquine reduced1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 49 💬
652Hydroxychloroquine sulfate1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--5件: 13, 46, 48, 53, 66 💬
653Hydroxychloroquine Sulfate 100 milligram (mg) Tab1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 218 💬
654Hydroxychloroquine Sulfate Tablets1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--2件: 48, 53 💬
655HYDROXYCHLOROQUINE SULPHATE1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--1件: 96 💬
656Hydroxycholoquine----1件: 46 💬
657Hydroxycloroquina----1件: 46 💬
658Hydroxyethyl Starch1件: Hydroxyethyl Starch1件: Hetastarch 💬 --1件: 97 💬
659Hydroxypropyl-beta-cyclodextrin----1件: 19 💬
660Hydroxypropyl-ß-cyclodextrin----1件: 19 💬
661Hydroxytyrosol1件: Hydroxytyrosol---1件: 13 💬
662Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬 1件: RRM2 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬10件: 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
663Hylase----1件: 46 💬
664Hymecromone1件: Hymecromone1件: Hymecromone 💬 --2件: 85, 94 💬
665HYNR-CS inj----1件: 2 💬
666HYNRCS-Allo inj----1件: 2 💬
667Hyperbaric Oxygen1件: Oxygen1件: Oxygen 💬 --3件: 46, 97, 269 💬
668Hyperbaric Oxygen Therapy1件: Oxygen1件: Oxygen 💬 --2件: 71, 90 💬
669Hyperbaric Oxygen Therapy (HBOT)1件: Oxygen1件: Oxygen 💬 --1件: 226 💬
670Hyperbaric oxygen treatment (HBOT)1件: Oxygen1件: Oxygen 💬 --6件: 13, 15, 36, 96, 97, 269 💬
671Hypercapnia Challenge using the device (RespirAct)----1件: 140 💬
672Hypercortisolism----1件: 75 💬
673Hyperglycemic clamp----1件: 299 💬
674Hyperglycemic Clamp with concurrent GIP infusion----1件: 299 💬
675Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299 💬
676Hyperimmune caprine serum----1件: 51 💬
677Hyperimmune caprine serum against HIV lysate----1件: 13 💬
678Hyperinsulinemic euglycemic clamp----3件: 316, 317, 344 💬
679Hyperium1件: Rilmenidine1件: Rilmenidine 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8 💬
680Hyperoxia----2件: 51, 85 💬
681Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 85 💬
682Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment1件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 85 💬
683Hyperpolarized 129-Xenon gas1件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 85 💬
684Hyperpolarized 129Xe----1件: 86 💬
685Hyperpolarized 13C-pyruvate----1件: 86 💬
686Hyperpolarized [1-13C]pyruvate1件: Pyruvic acid---2件: 2, 67 💬
687Hyperpolarized Helium-31件: Helium1件: Helium 💬 --1件: 299 💬
688Hyperpolarized Helium-3 MRI1件: Helium1件: Helium 💬 --1件: 228 💬
689Hyperpolarized Helium-3 MRI of the chest1件: Helium1件: Helium 💬 --1件: 299 💬
690Hyperpolarized Xe129----5件: 51, 85, 86, 88, 299 💬
691Hyperpolarized Xenon1件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 299 💬
692Hyperpolarized Xenon 1291件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 299 💬
693Hyperpolarized Xenon gas1件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 299 💬
694Hyperpolarized xenon-1291件: Xenon2件: Xenon ,
Xenon Xe 133 💬 		--1件: 299 💬
695Hypersaline----1件: 294 💬
696Hypersialylated immunoglobulin----1件: 63 💬
697Hypertonic bicarbonate----1件: 299 💬
698Hypertonic saline----3件: 222, 299, 340 💬
699Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299 💬
700Hypertonic saline (7%)----1件: 299 💬
701Hypertonic saline 6% -----1件: 299 💬
702Hypertonic Saline 7%----1件: 299 💬
703Hypertonic saline solution----1件: 299 💬
704Hypoestoxide----1件: 6 💬
705HypotonicTreprostinil Solution----1件: 86 💬
706Hypoxic Gas Mixture----1件: 6 💬
707HYQVIA----2件: 14, 65 💬
708HYQVIA - 100 MG/ML - SOLUZIONE PER INFUSIONE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 300 ML E FLACONCINO (VETRO) 15 ML - 1 FLACONCINO + 1 FLACONCINO----1件: 14 💬
709HyQvia 100 mg/ml solution for infusion for subcutaneous use----2件: 14, 65 💬
710Hyrimoz----1件: 271 💬
711HZN-1116----1件: 53 💬
712HZN-7734, VIB7734----1件: 49 💬
713HZN-7734, VIB7734, MEDI7734----1件: 49 💬
714HZN-825----2件: 51, 85 💬
715HZN-825 BID----1件: 51 💬
716HZN-825 QD----1件: 51 💬
717HZT-5011件: HZT-501---1件: 46 💬